These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 28303442)
21. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma. Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530 [TBL] [Abstract][Full Text] [Related]
22. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi. Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593 [TBL] [Abstract][Full Text] [Related]
23. Influence of asthma status on serotype-specific pneumococcal antibody levels. Jung JA; Kita H; Dhillon R; Jacobson RM; Nahm MH; Park M; Tsigrelis C; Juhn YJ Postgrad Med; 2010 Sep; 122(5):116-24. PubMed ID: 20861595 [TBL] [Abstract][Full Text] [Related]
24. [Splenectomy and pneumococcal vaccination]. Jeurissen A Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1142-3; author reply 1143. PubMed ID: 12822528 [No Abstract] [Full Text] [Related]
25. Humoral responses to oxidized low-density lipoprotein and related bacterial antigens after pneumococcal vaccine. Nguyen JT; Myers N; Palaia J; Georgopoulos A; Rubins JB; Janoff EN Transl Res; 2007 Sep; 150(3):172-9. PubMed ID: 17761370 [TBL] [Abstract][Full Text] [Related]
26. The zwitterionic type I Streptococcus pneumoniae polysaccharide does not induce memory B cell formation in humans. Trück J; Lazarus R; Clutterbuck EA; Bowman J; Kibwana E; Bateman EA; Pollard AJ Immunobiology; 2013 Mar; 218(3):368-72. PubMed ID: 22704520 [TBL] [Abstract][Full Text] [Related]
27. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease. Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368 [TBL] [Abstract][Full Text] [Related]
28. The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination. Rabquer B; Smithson SL; Shriner A; Julie Westerink MA Immunol Lett; 2006 Aug; 106(2):187-90. PubMed ID: 16781780 [TBL] [Abstract][Full Text] [Related]
29. Complement dependency of splenic localization of pneumococcal polysaccharide and conjugate vaccines. Breukels MA; Zandvoort A; Rijkers GT; Lodewijk ME; Klok PA; Harms G; Timens W Scand J Immunol; 2005 Apr; 61(4):322-8. PubMed ID: 15853914 [TBL] [Abstract][Full Text] [Related]
30. Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? Lipsitch M; Whitney CG; Zell E; Kaijalainen T; Dagan R; Malley R PLoS Med; 2005 Jan; 2(1):e15. PubMed ID: 15696204 [TBL] [Abstract][Full Text] [Related]
31. Blockade of CTLA-4 (CD152) enhances the murine antibody response to pneumococcal capsular polysaccharides. Boudewijns M; Jeurissen A; Wuyts M; Moens L; Boon L; Van Neerven JJ; Kasran A; Overbergh L; Lenaerts C; Waer M; Mathieu C; Ceuppens JL; Bossuyt X J Leukoc Biol; 2005 Nov; 78(5):1060-9. PubMed ID: 16081596 [TBL] [Abstract][Full Text] [Related]
32. Modulatory role of intravenous gammaglobulin (IgIV) on the in vitro antibody response to a pneumococcal polysaccharide antigen. Leiva LE; Monjure H; Sorensen RU J Clin Immunol; 2015 Feb; 35(2):206-12. PubMed ID: 25504423 [TBL] [Abstract][Full Text] [Related]
34. No evidence for impaired humoral immunity to pneumococcal proteins in Australian Aboriginal children with otitis media. Thornton RB; Kirkham LS; Corscadden KJ; Coates HL; Vijayasekaran S; Hillwood J; Toster S; Edminston P; Zhang G; Keil A; Richmond PC Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():119-125. PubMed ID: 28012512 [TBL] [Abstract][Full Text] [Related]
35. [Invasive pneumococcal infections in patients with primary immunodeficiency disorders]. Erdos M; Maródi L Orv Hetil; 2006 Apr; 147(17):799-804. PubMed ID: 16780188 [TBL] [Abstract][Full Text] [Related]
36. Prevention of pneumococcal infection in a patient with normal immunoglobulin levels but impaired polysaccharide antibody production. Cohn JA; Skorpinski E; Cohn JR Ann Allergy Asthma Immunol; 2006 Nov; 97(5):603-5. PubMed ID: 17165266 [TBL] [Abstract][Full Text] [Related]
37. Immunogenicity of 23-Valent Pneumococcal Vaccine in Children with Systemic Lupus Erythematosus. Alyasin S; Adab M; Hosseinpour A; Amin R; Babaei M Iran J Immunol; 2016 Sep; 13(3):204-19. PubMed ID: 27671512 [TBL] [Abstract][Full Text] [Related]
38. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae. Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027 [TBL] [Abstract][Full Text] [Related]
39. Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection. Zhang L; Li Z; Wan Z; Kilby A; Kilby JM; Jiang W Vaccine; 2015 Aug; 33(36):4430-6. PubMed ID: 26141012 [TBL] [Abstract][Full Text] [Related]
40. Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens by multiplexed bead assay. Borgers H; Moens L; Picard C; Jeurissen A; Raes M; Sauer K; Proesmans M; De Boeck K; Casanova JL; Meyts I; Bossuyt X Clin Immunol; 2010 Feb; 134(2):198-205. PubMed ID: 19914139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]